Company / Cash & Equivalents
Align Technology Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$1.1B
FY2025
5-year range
$937.4M / $1.1B
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#27 of 148
Health Care
What the data says
Align Technology's cash & equivalents of $1.1B is higher than 82% of companies in the Health Care sector (FY2025). Cash & Equivalents has fluctuated over the past 10 years, ranging from $389M in FY2016 to $1.1B in FY2021.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +2.6%. Top quartile in the Health Care sector.
Improved from $937M to $1.1B over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +5.1%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 148This company $1.1B Sector average $1.2B
▼
-7.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.6%, indicating consistent growth.
- In FY2025, cash & equivalents increased 4.9% year-over-year.
- Ranks #27 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +4.9% |
| FY2024 | $1.0B | +11.4% |
| FY2023 | $937.4M | -0.5% |
| FY2022 | $942.0M | -14.3% |
| FY2021 | $1.1B | +14.4% |
| FY2020 | $960.8M | +74.6% |
| FY2019 | $550.4M | -13.6% |
| FY2018 | $636.9M | +41.7% |
| FY2017 | $449.5M | +15.5% |
| FY2016 | $389.3M | +132.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026